HLA-E and neoplasm: This is particularly relevant in HCMV-infected tumours, where IFN-γ-rich environments may establish a negative feedback loop where immune activation induces checkpoint molecules (such as PD-L1 and HLA-E), which in turn suppress immune effector function [94,109].